| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:540.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology, University of Aarhus, Denmark.
Correspondence to Dr Stinne Kvist, Department of Pharmacology, Bartholin Building, University of Aarhus, 8000 Aarhus C, Denmark. E-mail stinne.kvist{at}dadlnet.dk
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, renal rats hypertrophy arteries blood pressure heart kidney remodeling
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Health status was supervised by the local animal welfare officer, and all experiments were performed according to Danish legislation.
Protocol for Grouping
The rats were divided into a normotensive, sham-operated group (sham) of 30 rats and a hypertensive 1K-1C group of 101 rats. All operations were performed in rats 6 to 7 weeks of age. The sham rats were subdivided in 2 groups with 15 rats in each, which were studied at 14 and 18 weeks of age, respectively. The 1K-1C rats were randomly subdivided into 7 groups: 2 groups with 15 rats in each, which served as hypertensive controls (control 1K-1C) at 14 and 18 weeks of age, respectively, and 5 groups that were declipped (declipped 1K-1C) at 14 weeks of age, and the rats were subsequently killed 6 hours (16 rats), 24 hours (14 rats), 1 week (16 rats), 4 weeks (15 rats), and 8 weeks (10 rats) after declipping.
Blood Pressure
Systolic blood pressure was measured by the tail-cuff method with a plethysmograph (LE5000, Lettica). Before measurements, rats were preheated for 20 to 30 minutes at 35°C in their cages. Rats were then moved to a small heated container, where the rats were trained to stay for periods up to 20 minutes. In each rat, 4 to 6 measurements were made and mean values were used. The equipment was calibrated every day by comparison with a mercury column.
Blood pressure measurements in 1K-1C rats were made before insertion of clips, 2 weeks after and every week hereafter until systolic blood pressure increased above 160 mm Hg. Afterward, blood pressure was measured in control 1K-1C rats at the time of killing, whereas in declipped 1K-1C it was measured just before declipping and at the time of killing. Blood pressure measurements in the sham rats took place just before sham operation and at the time of killing.
Preparation of Sham and 1K-1C Rats
Rats were anesthetized with 7 mg/kg IP methohexital, and, if necessary, supplemented with small doses of methohexital directly to the abdominal cavity during the operation. The fur was shaved off the abdomen and the operation was performed through a 4-cm longitudinal incision as described by Stacy and Prewitt.16 The left renal artery was dissected free of fat and connective tissue, and in animals chosen to be hypertensive, a U-shaped silver clip, 230- to 250-µm internal diameter, was placed around the renal artery as far from the kidney as possible. Afterward, the right kidney was removed and the incision was closed by suturing the muscular layer and by attaching wound clips to the skin. Sham rats were prepared by the same procedure as the 1K-1C rats apart from the application of a clip. In declipped rats, the clips were gently removed from 1K-1C rats after cleaning for adhesive tissue in an operation through the initial incision.
In Vitro Protocols
Dissection
After killing with exposure to CO2, the rat was weighed and heart, kidney, and a piece of the mesenteric vascular bed were cut out and placed in ice-cold physiological salt solution (PSS, see below for composition). The atria of the heart were cut away and the heart was wiped with paper and weighed. The kidney was cleaned from fat and connective tissue, wiped with paper, and weighed. From the mesenteric vascular bed, 2 segments of vessels from the third branch, 2 mm long and with an internal diameter of
230 µm, were dissected free from fat and mounted in a wire myograph.19 In the myograph, vessels were bubbled with 5% CO2 in air and allowed to equilibrate at 37°C for 30 minutes.
Morphometric Measurements
After equilibration, the myograph was placed on a microscope and wall structure was measured at 6 different positions by an ocular micrometer.20 Vessels were then set to normalized diameter, l1, that is, 0.9 times the internal diameter the vessels would have if fully relaxed and exposed to a transmural pressure of 100 mm Hg, calculated on the basis of the Laplace relation.19,21 Mean of media thickness and internal diameter was expressed as media/lumen ratio.
Functional Measurements
After normalization, vessels were exposed to PSS with potassium (K-PSS, see below for composition) for 2 minutes as a measure of contractile capacity. A concentration response curve to acetylcholine (10-810-5 mol/L) was performed on top of a precontraction with 3 µmol/L noradrenaline by adding the drug in half-logarithmic concentrations to the bath every second minute.
Exclusion Criteria
Rats were excluded from the study if (1) systolic blood pressure in rats with clips was below 165 mm Hg after 8 weeks; (2) systolic blood pressure in sham rats was above 140 mm Hg; (3) internal diameter of the vessels in the myograph was below 150 µm or above 350 µm; (4) active pressure response of the vessels [active wall tension/(l1/2)]21 to K-PSS for 2 minutes was below 13 kPa; (5) if renal scars caused by renal infarction were present at the time of killing.
Solutions and Drugs
Physiological salt solution consisted of (mmol/L): 119 NaCl, 4.7 KCl, 1.17 MgSO4,7H2O, 25 NaHCO3, 1.18 KH2PO4, 0.0026 EDTA, 5.5 glucose, and 1.6 CaCl2. In K-PSS, NaCl was replaced with equimolar KCl.
Drugs used were methohexital (Brietal7, Lilly), (-)noradrenaline hydrochloride (Sigma Chemicals Co), and acetylcholine (Fluka AG).
Data Analysis
Analysis was based on the mean of the 2 vessels taken from each animal. All values are given as mean±SEM. One-way ANOVA was used for comparisons between groups. If ANOVA showed a significant difference, data were analyzed by the Student 2-tailed, unpaired t test and linear regression for specified groups. A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
Before application of clips, the average weight of the rats was 163±3 g, and the average systolic blood pressure and heart rate were 116±1 mm Hg and 409±4 beats/min, respectively. There were no differences in the parameters between the groups.
Blood Pressure
The blood pressure of the 1K-1C rats was increased 2 weeks after application of clips and increased further until 6 weeks after application of clips. Afterward, the blood pressure remained stable. After declipping, there was an immediate fall in blood pressure to the control level within 6 hours. The blood pressure decreased further and reached the level of the sham rats 1 week after declipping. The blood pressure then remained stable until the end of follow-up at 22 weeks of age, 8 weeks after declipping. The blood pressure in the sham rats gradually increased between 6 and 7 weeks and 18 weeks of age (Figure 1). There were no differences in heart rate between any of the groups (data not shown). Mean heart rate for all groups was 409±4 beats/min.
|
Heart, Kidney, and Body Weight
The weights of the kidney and the body of the 1K-1C rats were reduced compared with that in the sham rats at 14 weeks of age, but the differences had disappeared at 18 weeks of age, 4 weeks after declipping (Table 1). Kidney weight as a fraction of body weight was similar for all groups. The heart/body weight ratio was increased in 1K-1C rats at 14 weeks of age compared with sham rats. Between 14 and 18 weeks, there were no changes in the heart/body weight ratio in either the sham rats or in the control 1K-1C rats. In declipped 1K-1C rats, the heart/body ratio declined gradually and was significantly reduced after 1 week and not significantly different from sham rats within 4 weeks (Figure 2).
|
|
Morphometric Characteristics of the Vessel Wall
The morphometric data are shown in Table 2 and Figure 3. When rats were 14 weeks old, 8 weeks after the application of clips, the media/lumen ratio of mesenteric resistance arteries was increased in the 1K-1C rats compared with the age-matched sham rats. There was no further increment in media/lumen ratio between 14 and 18 weeks of age, either for sham rats or control 1K-1C rats. Declipping did not induce regression of media/lumen ratio of mesenteric resistance arteries (ANOVA for declipped 1K-1C groups: P=0.11). Linear regression of media/lumen ratio of resistance arteries from declipped 1K-1C rats showed a tendency for regression (P=0.07).
|
|
Media area and media thickness of the mesenteric resistance arteries were increased in the control 1K-1C rats compared with the sham rats at 14 and 18 weeks of age. There was no regression of media area and media thickness after declipping. There were no significant differences in internal diameter of arteries from sham rats, control 1K-1C rats, or declipped 1K-1C rats.
Functional Measurements
No functional differences were found (Table 3). Thus, there were no differences in maximal effect of acetylcholine between the sham, control 1K-1C, or declipped 1K-1C groups. The vessels relaxed by
65% of the noradrenaline preconstriction when exposed to acetylcholine in all groups. The acetylcholine concentration for half-maximal relaxation was similar in all groups (compared with 0.1 µmol/L, data not shown). There were no differences in contractile responses to noradrenaline and K-PSS between the groups.
|
| Discussion |
|---|
|
|
|---|
Given the strong association between blood pressure and vascular structure, as discussed in the Introduction, it was surprising that the structure of the small arteries was not significantly regressed 8 weeks after declipping, despite normal pressure for almost the whole of this time. This is in apparent contrast to the relation seen in SHR. Here, for example, treatment of established hypertension with different vasodilator antihypertensive drugs for 8 to 12 weeks results in a gradual reduction of blood pressure and regression of cardiac hypertrophy22,23 and regression of abnormal structure of small resistance vessels.23,24 Similarly, in humans, successful treatment of essential hypertension with vasodilators causes regression of heart weight and resistance vessel structure, at least after 1 year.7,25,26 As described in the Introduction, the retarded regression of the hypertrophy of the heart despite fast normalization of blood pressure in renovascular hypertensive rats was also observed by Friberg and Nordborg14 and Lundgren,15 and similar findings were observed in the arterioles of the rat cremaster muscle by Stacy and Prewitt16 and indirectly in the hindquarter perfusion preparation by Lundgren.15 These indications of fast normalization of blood pressure and the retarded or absent regression of heart weight and resistance vessel structure in declipped renovascular hypertensive rats are now strongly supported by the direct investigations of the structure of the vessels in our experiments. It appears therefore to be a general finding in these animals that hypertrophy of vessels and heart are not able to keep blood pressure high, and any hypertensive action of the hypertrophy is eliminated either by removal of a vasoconstrictor agent or by activation of a vasodilator agent. The existence of such an agent has also been proposed by Muirhead et al,27 who provided evidence for an antihypertensive neutral renomedullary lipid, medullipin, suggested to be released from the declipped kidney.27,28
The divergence in the rates of normalization in blood pressure and cardiovascular structure seen in this study confirms other situations in which blood pressure and cardiovascular structure are not always tightly associated. Thus, although this tight association is normally seen in most forms of hypertension, as discussed above, specific interventions may interrupt this association. For example, treatment of SHR29 or of patients with essential hypertension patients with ß-blockers30,31 causes blood pressure reduction without affecting small-artery structure. As another example, withdrawal of treatment, both in humans32 and in SHR,26 induces a rise in blood pressure that is not time-related to changes in resistance artery structure, and the data emphasize that abnormal vascular structure is not in itself sufficient to maintain a high blood pressure. As regards normalization of blood pressure, normalization of resistance vessel structure may not therefore be important. However, it cannot be excluded that abnormal structure may have other consequences, such as reduced vascular reserve33; further studies are, however, needed to establish this.
The role of the endothelium in hypertension has been investigated intensively, and the results in normotensive rats and hypertensive rats of different kinds are conflicting. However, as regards renovascular hypertensive rats, there has been general agreement that the response to acetylcholine is reduced (in 1K-1C as well as in 2K-1C rats) compared with normotensive rats.3438 This is in contrast to our results that showed no differences in response to acetylcholine. We found no obvious reason for the conflicting results because the conditions we have used are in general similar, such that some subtle difference in our protocol probably accounts for the discrepancy.
It was of some concern that approximately one third of the animals did not survive the consequences of the operation, which we ascribed to the crucial importance of the clip aperture: Variations of
30 µm were found to span the difference between no hypertensive effects and induction of uremia.17 However, our finding that for the survivors after placement of the clip, blood pressure was elevated after 2 weeks and remained stable after 6 weeks is in agreement with the findings of Stacy and Prewitt.16 The hypertrophy of the heart and increased media/lumen ratio and media area of the resistance arteries is also in agreement with previous findings,39 as is the normalization of the weight of the clipped kidney after an initial weight reduction.17 The rapid fall in blood pressure within a few hours after declipping is also similar to that previously reported,40,41 although it took more than 1 day to normalize. The model thus appears to have been satisfactory.
Perspectives
This study has provided clear evidence that rapid reduction of blood pressure, achieved in this study by declipping of 1K-1C rats, is not necessarily accompanied by a corresponding normalization of resistance vessel structure over a period of 8 weeks, although heart weight was normalized after 4 weeks. This thus provides definitive evidence that an abnormal resistance vessel structure is not in itself sufficient to maintain a high blood pressure. Conversely, reduction of blood pressure does not in itself necessarily result in a rapid normalization of resistance vessel structure. As indicated, treatment of genetic hypertension does in some cases result in normalization of resistance vessel structure, but it is not known how quickly this occurs. Furthermore, some treatments of genetic hypertension do not normalize resistance vessel structure even after 1 year or more. Taken together with the results of the present study, this indicates a need for a better understanding of the mechanisms that allow normalization of resistance vessel structure in the treatment of hypertension. The results of this study also underline the need for understanding the degree to which an abnormal resistance vessel structure should be a target for antihypertensive therapy.
| Acknowledgments |
|---|
Received July 24, 2002; first decision August 14, 2002; accepted December 18, 2002.
| References |
|---|
|
|
|---|
2. Li JS, Schiffrin EL. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1996; 28: 6874.[CrossRef][Medline] [Order article via Infotrieve]
3. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension. 1993; 21: 391397.
4. Muiesan ML, Rizzoni D, Salvetti M, Porteri E, Monteduro C, Guelfi D, Castellano M, Garavelli G, Agabiti-Rosei E. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens. 2002; 20: 14391444.[CrossRef][Medline] [Order article via Infotrieve]
5. Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, Walker JF, Hahn RT, Dahlof B. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial. Circulation. 2001; 104: 12481254.
6. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996; 28: 785790.
7. Schiffrin EL. Vascular changes in hypertension in response to drug treatment: effects of angiotensin receptor blockers. Can J Cardiol. 2002; 18 (suppl A): 15A-18A.[Medline] [Order article via Infotrieve]
8. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982; 62: 347504.
9. Korner PI, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995; 25: 610619.
10. Mulvany MJ. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. J Hum Hypertension. 1995; 9: 479485.[Medline] [Order article via Infotrieve]
11. Heagerty AM, Izzard AS. Small-artery changes in hypertension. J Hypertens. 1995; 13: 15601565.[Medline] [Order article via Infotrieve]
12. Russell GI, Brice JM, Bing RF, Swales JD, Thurston H. Haemodynamic changes after surgical reversal of chronic two-kidney, one-clip hypertension in the rat. Clin Sci. 1981; 61 (suppl 7): 117s119s.[Medline] [Order article via Infotrieve]
13. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981; 241: H381H388.[Medline] [Order article via Infotrieve]
14. Friberg P, Nordborg C. Functional, morphological and metabolic characteristics of isolated hearts from normotensive and spontaneously hypertensive rats before, during and after renal hypertension. Acta Physiol Scand. 1986; 126: 161171.[Medline] [Order article via Infotrieve]
15. Lundgren Y. Regression of structural cardiovascular changes after reversal of experimental renal hypertension in rats. Acta Physiol Scand. 1974; 91: 275285.[Medline] [Order article via Infotrieve]
16. Stacy DL, Prewitt RL. Effects of chronic hypertension and its reversal on arteries and arterioles. Circ Res. 1989; 65: 869879.
17. Murphy WR, Coleman TG, Smith TL, Stanek KA. Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension. Hypertension. 1984; 6: 6874.
18. Skeggs LT, Kahn JR, Levine M, Dorer FE, Lentz KE. Chronic one-kidney hypertension in rabbits. I. treatment with kidney extracts. Circ Res. 1975; 37: 715724.
19. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977; 41: 1926.
20. Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978; 43: 854864.
21. Buus NH, VanBavel E, Mulvany MJ. Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations. Br J Pharmacol. 1994; 112: 579587.[Medline] [Order article via Infotrieve]
22. Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats: effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens. 2001; 14: 713.[CrossRef][Medline] [Order article via Infotrieve]
23. Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 1998; 16: 457466.[CrossRef][Medline] [Order article via Infotrieve]
24. Gillies LK, Lee RM. Effects of chronic blockade of angiotensin II receptor on the maintenance of hypertension and vascular changes in spontaneously hypertensive rats. Can J Physiol Pharmacol. 1996; 74: 10611069.[CrossRef][Medline] [Order article via Infotrieve]
25. Sihm I, Thygesen K, Krusell LR, Lederballe O. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide. Blood Press. 2000; 9: 346354.[CrossRef][Medline] [Order article via Infotrieve]
26. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension. 1994; 23: 659666.
27. Muirhead EE, Pitcock JA, Nasjletti A, Brown P, Brooks B. The antihypertensive function of the kidney: its elucidation by captopril plus unclipping. Hypertension. 1985; 7 (suppl I): I-127I-135.[Medline] [Order article via Infotrieve]
28. Thomas CJ, Woods RL, Evans RG, Alcorn D, Christy IJ, Anderson WP. Evidence for a renomedullary vasodepressor hormone. Clin Exp Pharmacol Physiol. 1996; 23: 777785.[Medline] [Order article via Infotrieve]
29. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens. 1989; 7: 8390.[Medline] [Order article via Infotrieve]
30. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994; 23: 8391.
31. Thybo N, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995; 25: 474481.
32. Korner PI, Bobik A, Jennings GL, Angus JA, Anderson WP. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Pharmacol. 1991; 17 (suppl 2): S25S32.
33. Strauer BE, Schwartzkopff B. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease. Blood Press. 1997; 2 (suppl): 612.[Medline] [Order article via Infotrieve]
34. Bennett MA, Thurston H. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats. Clin Sci (Colch). 1996; 90: 2129.[Medline] [Order article via Infotrieve]
35. Lee BH, Shin HS. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats. Jpn J Pharmacol. 1997; 74: 8390.[Medline] [Order article via Infotrieve]
36. Nakamura T, Prewitt RL. Alteration of endothelial function in arterioles of renal hypertensive rats at two levels of vascular tone. J Hypertens. 1992; 10: 621627.[Medline] [Order article via Infotrieve]
37. Ortenberg JM, Cook AK, Inscho EW, Carmines PK. Attenuated afferent arteriolar response to acetylcholine in Goldblatt hypertension. Hypertension. 1992; 19: 785789.
38. Angus JA, Dyke AC, Jennings GL, Korner PI, Sudhir K, Ward JE, Wright CE. Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int. 1992; 41 (suppl 37): S73S78.
39. Korsgaard N, Mulvany MJ. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension. 1988; 12: 162167.
40. Byrom FB, Dodson LF. The mechanism of the vicious circle in chronic hypertension. Clin Sci. 1949; 8: 110.[Medline] [Order article via Infotrieve]
41. ten Berg R, de Jong W. Time course of the enhanced blood pressure response to reinduction of renal artery stenosis in unclipped renal hypertensive rats. Pflugers Arch. 1979; 380: 133137.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |